As a cardiologist who spends the majority of her time caring for patients, participating in a conference bringing together leaders from all sectors of the healthcare industry has been an eye opening experience.
Medical research costs money, and as our national and international financial woes continue to deepen, investors are demanding less risk but more innovation. Regulation of the pharmaceutical industry is essential to protect our safety and well-being, yet the more stringent the rules become, the more difficult it is for investors to take a chance on new ideas.
Amongst the people I have had the opportunity to meet are several involved in the earliest stages of medical research. It may take 10 to 15 years for a brilliant idea to make it from the research bench to the drugstore, with many steps in between, and no guarantees of success.
There are no easy answers when it comes to optimizing our investment in our nation’s health. Just as with the high-tech revolution, it will take innovators who are able to create new ideas and solutions, without being tethered to the mistakes and outdated modalities of the past.